CCL4L2 and Recurrent upper respiratory tract infections: MCP-1, MIP-1 alpha, MIP-1 beta, and RANTES were each evaluated in a single study that reported no significant differences in their levels in saliva or blood of bacterial versus viral upper respiratory tract infections [19].